Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Related Citations for PubMed (Select 10627488)

1.

Respiratory syncytial virus genetic and antigenic diversity.

Sullender WM.

Clin Microbiol Rev. 2000 Jan;13(1):1-15, table of contents. Review.

2.

Epidemiology. Does viral diversity matter?

Medley GF, Nokes DJ.

Science. 2009 Jul 17;325(5938):274-5. doi: 10.1126/science.1177475. No abstract available.

PMID:
19608903
3.

Genetic diversity among respiratory syncytial viruses that have caused repeated infections in children from rural India.

Parveen S, Broor S, Kapoor SK, Fowler K, Sullender WM.

J Med Virol. 2006 May;78(5):659-65.

PMID:
16555275
4.

Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein.

García O, Martín M, Dopazo J, Arbiza J, Frabasile S, Russi J, Hortal M, Perez-Breña P, Martínez I, García-Barreno B, et al.

J Virol. 1994 Sep;68(9):5448-59.

5.

Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.

Li X, Sambhara S, Li CX, Ettorre L, Switzer I, Cates G, James O, Parrington M, Oomen R, Du RP, Klein M.

Virology. 2000 Mar 30;269(1):54-65.

6.
7.
8.

Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.

Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.

Vaccine. 2007 Oct 10;25(41):7132-44. Epub 2007 Aug 21.

PMID:
17850933
9.

Genetic variability among group A and B respiratory syncytial viruses in Mozambique: identification of a new cluster of group B isolates.

Roca A, Loscertales MP, Quintó L, Pérez-Breña P, Vaz N, Alonso PL, Saiz JC.

J Gen Virol. 2001 Jan;82(Pt 1):103-11.

10.

Antigenic and genomic diversity within group A respiratory syncytial virus.

Storch GA, Anderson LJ, Park CS, Tsou C, Dohner DE.

J Infect Dis. 1991 Apr;163(4):858-61.

PMID:
2010638
11.

Antigenic diversity of respiratory syncytial viruses and its implication for immunoprophylaxis in ruminants.

Duncan RB Jr, Potgieter LN.

Vet Microbiol. 1993 Nov;37(3-4):319-41. Review.

PMID:
8116189
12.

Intragroup antigenic diversity of human respiratory syncytial virus (group A) isolated in Argentina and Chile.

Galiano MC, Luchsinger V, Videla CM, De Souza L, Puch SS, Palomo C, Ricarte C, Ebekian B, Avendaño L, Carballal G.

J Med Virol. 2005 Oct;77(2):311-6.

PMID:
16121383
13.

Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya.

Agoti CN, Mwihuri AG, Sande CJ, Onyango CO, Medley GF, Cane PA, Nokes DJ.

J Infect Dis. 2012 Nov 15;206(10):1532-41. doi: 10.1093/infdis/jis570. Epub 2012 Sep 10.

14.

Genetic diversity of respiratory syncytial virus isolated during an epidemic period from children of northeastern Brazil.

Moura FE, Blanc A, Frabasile S, Delfraro A, de Sierra MJ, Tome L, Ramos EA, Siqueira MM, Arbiza J.

J Med Virol. 2004 Sep;74(1):156-60.

PMID:
15258982
16.

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.

Piedra PA, Grace S, Jewell A, Spinelli S, Bunting D, Hogerman DA, Malinoski F, Hiatt PW.

Pediatr Infect Dis J. 1996 Jan;15(1):23-31.

PMID:
8684872
17.

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.

Piedra PA, Grace S, Jewell A, Spinelli S, Hogerman DA, Malinoski F, Hiatt PW.

Pediatr Infect Dis J. 1998 Mar;17(3):217-24.

PMID:
9535249
18.

Molecular epidemiology of human respiratory syncytial virus in Uruguay: 1985-2001--a review.

Arbiza J, Delfraro A, Frabasile S.

Mem Inst Oswaldo Cruz. 2005 May;100(3):221-30. Epub 2005 Aug 15. Review.

19.

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.

Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, Gruber W, Murphy BR, Collins PL.

J Infect Dis. 2005 Apr 1;191(7):1093-104. Epub 2005 Mar 1.

20.

Immunological properties of plaque purified strains of live attenuated respiratory syncytial virus (RSV) for human vaccine.

Herlocher ML, Ewasyshyn M, Sambhara S, Gharaee-Kermani M, Cho D, Lai J, Klein M, Maassab HF.

Vaccine. 1999 Jan;17(2):172-81.

PMID:
9987152
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk